You are here

Prevnar 13

Merck's 15-strain flu shot matches Prevnar 13 in late-stage infant study, but Pfizer's next-gen shot looms

Endpoints

Wed, 08/25/21 - 11:16 am

clinical trials

Merck's Pneumococcal Vaccine Lands FDA Nod, Just Few Weeks After Its Rival

Benzinga

Mon, 07/19/21 - 10:55 am

pneumococcal disease

Prevnar 13 lags amid COVID-19 vaccine rollouts, but Pfizer sees a way to boost the franchise

Fierce Pharma

Tue, 05/4/21 - 10:38 pm

pneumococcal disease

Ready, set, pneumococcal vaccine: Pfizer teams up again with former football pro Terry Bradshaw

Fierce Pharma

Fri, 02/12/21 - 10:58 am

celebrity endorsements

pneumococcal disease

Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA

Endpoints

Tue, 01/12/21 - 10:59 am

pneumococcal disease

priority review

Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again

Fierce Biotech

Tue, 10/20/20 - 10:38 am

clinical trials

pneumococcal disease

Merck’s pneumonia vaccine posts two more hits

EP Vantage

Wed, 09/9/20 - 11:04 am

Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China

Fierce Pharma

Sun, 01/5/20 - 07:07 pm

Pfizer touts successor to Prevnar 13

Biopharma Dive

Mon, 09/9/19 - 08:02 pm

pneumococcal disease

U.S. advisory panel stops short of broad recommendations for two common vaccines

Stat

Wed, 06/26/19 - 05:15 pm

advisory panels

Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine

Endpoints

Wed, 05/8/19 - 12:30 pm

pneumococcal disease

FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game

Endpoints

Thu, 01/31/19 - 11:27 am

breakthrough status

Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3

Fierce Pharma

Wed, 04/18/18 - 09:50 am

pneumococcal disease

Don't sweat Prevnar's problems, Pfizer R&D chief says. New vaccines are on their way

Fierce Pharma

Tue, 04/10/18 - 10:23 pm

Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180

Fierce Pharma

Wed, 11/29/17 - 09:57 am

Pneumonia vaccine triples protection in animal models

Fierce Biotech

Sat, 10/21/17 - 10:20 am

antibiotic resistance

Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates

Fierce Pharma

Tue, 09/12/17 - 09:47 pm

Top 25 vaccine products in 2016, based on U.S. sales

Medical Marketing and Media

Mon, 08/28/17 - 10:33 pm

Pfizer Wins Indian Patent on Prevnar 13 Vaccine

RAPS.org

Tue, 08/22/17 - 06:43 pm

SutroVax raises $64M with plans to challenge Pfizer’s megablockbuster Prevnar 13 for the heavyweight title in vaccines

Endpoints

Tue, 03/21/17 - 09:46 am

pneumococcal disease

Pages